Author:
Verschraagen Miranda,Kedde Marc A.,Hausheer Frederick H.,van der Vijgh Wim J. F.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference26 articles.
1. Abe R, Akiyoshi T, Baba T (1990) 'Two-route chemotherapy' using cisplatin and its neutralizing agent, sodium thiosulfate, for intraperitoneal cancer. Oncology 47:422
2. Berry JM, Jacobs C, Sikic B, Halsey J, Borch RF (1990) Modification of cisplatin toxicity with diethyldithiocarbamate. J Clin Oncol 8:1585
3. Boven E, Verschraagen M, Hulscher TM, Erkelens CAM, Hausheer FH, Pinedo HM, Van der Vijgh WJF (2002) BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts. Eur J Cancer 38:1148
4. Cavalletti E, Cavaletti G, Tredici G, Oggioni N, Spinelli S, Reddy D, Zhao M, Wu M, Hausheer F (1999) Oral and intravenous BNP7787 protects against paclitaxel-mediated neurotoxicity in Wistar rats. Proc Am Assoc Cancer Res 40:398
5. Daley-Yates PT, McBrien DCH (1984) Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin. Biochem Pharmacol 33:3063
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献